Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine vs sufentanil for hysteroscopic surgery sedation
ChiCTR2400091785Phase 4Not yet recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine (2 arms), sponsored by Yancheng First People's Hospital. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
Beyond the preview
Go deeper on ChiCTR2400091785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091785.